药品添加剂制造中的辅助剂:全面探索用于增强3D打印的聚合物材料选择
Christian Muehlenfeld1, Patrick Duffy2, Fengyuan Yang3
1Ashland Life Sciences R&D, 40599 Düsseldorf, Germany.
Pharmaceutics
|March 28, 2024
概括
本综述探讨了用于制药3D打印 (3DP) 的聚合物选择. 了解材料特性是优化3DP流程和药物输送设备的关键.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
- 生物技术是生物技术.
背景情况:
- 增材制造 (AM) 或3D打印 (3DP) 正在彻底改变制药发展.
- 聚合物选择是成功制药3DP的关键,但复杂的因素.
- 对于研究人员和配方者来说,对聚合物性质的基本理解是必不可少的.
研究的目的:
- 为了提供一个全面的概述的聚合物应用在医药3DP.
- 阐明材料特性对3DP工艺和产品质量的影响.
- 作为在制药3DP中选择合适的聚合物的基本指南.
主要方法:
- 药品中添加剂制造技术的文献综述.
- 在3DP中分析聚合物物理化学性质的作用.
- 对药物输送装置和剂量形式的聚合物选择信息的综合.
主要成果:
- 详细检查用于制药3DP的各种聚合物.
- 了解聚合物特性如何影响可打印性,药物释放和设备性能.
- 基于预期应用的聚合物选择的关键考虑因素的确定.
结论:
- 有效的聚合物选择对于制药3DP的发展至关重要.
- 了解聚合物-材料相互作用对于开发创新的3D打印药物和医疗器械至关重要.
- 本综述提供了必要的指导,通过明智的聚合物选择,充分利用制药3DP的全部潜力.
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


